MONTORSI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 12.362
AS - Asia 8.990
NA - Nord America 7.714
SA - Sud America 718
AF - Africa 203
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 12
Totale 30.084
Nazione #
US - Stati Uniti d'America 7.543
SE - Svezia 4.379
CN - Cina 3.132
SG - Singapore 2.730
IT - Italia 2.707
RU - Federazione Russa 2.223
HK - Hong Kong 2.089
RO - Romania 806
BR - Brasile 639
FI - Finlandia 530
DE - Germania 461
IN - India 329
IE - Irlanda 319
NL - Olanda 239
GB - Regno Unito 160
ID - Indonesia 140
JP - Giappone 133
FR - Francia 101
TR - Turchia 99
CA - Canada 96
AU - Australia 71
IR - Iran 65
AT - Austria 64
MX - Messico 55
ES - Italia 52
NG - Nigeria 51
UA - Ucraina 49
PK - Pakistan 44
PL - Polonia 41
BE - Belgio 36
CH - Svizzera 36
TW - Taiwan 28
EG - Egitto 27
IQ - Iraq 21
GR - Grecia 20
KR - Corea 20
MA - Marocco 19
CO - Colombia 18
LT - Lituania 18
NO - Norvegia 18
BD - Bangladesh 17
CZ - Repubblica Ceca 17
DZ - Algeria 16
TZ - Tanzania 16
IL - Israele 15
KE - Kenya 15
PH - Filippine 14
UZ - Uzbekistan 14
AR - Argentina 13
EC - Ecuador 13
TN - Tunisia 13
VN - Vietnam 13
RS - Serbia 12
BG - Bulgaria 11
TH - Thailandia 11
ZA - Sudafrica 11
CL - Cile 10
MY - Malesia 10
DK - Danimarca 9
EU - Europa 9
HR - Croazia 9
NZ - Nuova Zelanda 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
GH - Ghana 8
NP - Nepal 8
PT - Portogallo 8
VE - Venezuela 8
HU - Ungheria 7
JO - Giordania 7
LU - Lussemburgo 7
OM - Oman 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
CM - Camerun 5
LK - Sri Lanka 5
PA - Panama 5
PG - Papua Nuova Guinea 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BO - Bolivia 4
BY - Bielorussia 4
JM - Giamaica 4
KZ - Kazakistan 4
MK - Macedonia 4
MW - Malawi 4
AM - Armenia 3
CR - Costa Rica 3
GN - Guinea 3
SI - Slovenia 3
AL - Albania 2
CU - Cuba 2
GM - Gambi 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LR - Liberia 2
LV - Lettonia 2
NI - Nicaragua 2
Totale 30.058
Città #
Shanghai 2.196
Lawrence 2.115
Princeton 2.108
Hong Kong 2.056
Singapore 1.657
Moscow 1.058
Milan 636
Ashburn 630
Helsinki 501
New York 433
Dublin 315
Boardman 223
Rome 187
Pune 156
Turin 88
Nuremberg 81
Los Angeles 77
Seattle 75
Dallas 72
Guangzhou 64
Washington 63
Naples 51
São Paulo 49
Bologna 48
Florence 43
Hanover 43
Borås 39
Paris 37
Beijing 36
Vienna 35
Sydney 33
Pisa 31
Reston 31
Munich 30
Amsterdam 29
Hangzhou 29
Bengaluru 27
Delhi 27
Istanbul 27
Brooklyn 26
Tokyo 26
Bari 25
Council Bluffs 25
London 25
Genoa 23
Santa Clara 23
Shenzhen 23
Brescia 22
Brussels 22
Lappeenranta 21
Central 20
Frankfurt am Main 20
Mumbai 20
Padova 20
Ankara 19
Jakarta 19
Makassar 19
Palermo 19
Rio de Janeiro 19
St Petersburg 19
Belo Horizonte 18
Pekanbaru 18
Lagos 17
Parma 17
Pescara 17
Chennai 16
Dar es Salaam 16
Oldenburg 16
Toronto 16
Jiaxing 15
Karachi 15
Monza 15
Xi'an 15
Azzano San Paolo 14
Chicago 14
Hyderabad 14
Perugia 14
Berlin 13
Campinas 13
Redwood City 13
Warsaw 13
Cairo 12
Goiânia 12
Lugano 12
Porto Alegre 12
Prague 12
Rockville 12
Tashkent 12
Treviso 12
Wuxi 12
Rozzano 11
Abuja 10
Athens 10
Belgrade 10
Cincinnati 10
Curitiba 10
Ho Chi Minh City 10
Nairobi 10
Perth 10
Quanzhou 10
Totale 16.419
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.092
Benign Prostatic Hyperplasia and Its Aetiologies 387
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 349
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 341
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 302
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 294
High serum alpha-fetoprotein levels in primary infertile men 284
Women's sexual dysfunction: a pathophysiological review 237
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 124
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 99
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 96
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 75
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 72
Prediction of Sexual Function After Radical Prostatectomy 61
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 60
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 59
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 58
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 57
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 57
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 54
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 53
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 52
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 52
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 52
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 50
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 50
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 49
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 48
Testosterone in males with COVID-19: A twelve-month cohort study 47
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 46
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 46
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 45
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 44
Pelvic lymph node dissection in prostate cancer 44
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 44
Prostate cancer nomograms: an update 43
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 43
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 41
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 41
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 41
Infertility as a Proxy of Men's Health: Still a long way to go 41
Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation 40
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 40
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 39
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 39
QUALI SONO I PAZIENTI A RISCHIO DI RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO OLTRE I 10 ANNI DI FOLLOW-UP DOPO PROSTATECTOMIA RADICALE? 39
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 39
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 39
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 38
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 38
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 37
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 37
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial 37
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 37
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 36
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 36
Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data 36
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence 36
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 36
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 36
How to Select the Optimal Candidates for Renal Mass Biopsy 36
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 35
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 35
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 35
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 35
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 35
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer 35
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 35
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 34
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy 34
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 34
Individual Patient Data from Registrational Trials of Silodosin in the Treatment of Non-neurogenic Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement: Subgroup Analyses of Efficacy and Safety Data 34
Does sildenafil enhance quality of nocturnal erections in healthy young men? A NPT-RigiScan (TM) study 34
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 34
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 34
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 34
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 33
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 33
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 33
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 33
Radical prostatectomy after previous prostate surgery: Clinical and functional outcomes 33
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 33
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 33
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 33
Parenchymal biopsy in the management of patients with renal cancer 33
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 33
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 32
A global approach to improving penile cancer care 32
Leydig cell tumour of the testis: presentation, therapy, long-term follow-up and the role of organ-sparing surgery in a single-institution experience 32
ELETTROSTIMOLAZIONE INTRAOPERATORIA DEI NERVI CAVERNOSI CON ELETTRODI IMPIANTABILI 32
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 32
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 32
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 32
Infertile couples still undergo assisted reproductive treatments without initial andrological evaluation in the real-life setting: A failure to adhere to guidelines? 32
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 32
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 32
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 31
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 31
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 31
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 31
Totale 7.172
Categoria #
all - tutte 532.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 532.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 1 7 3 0 0
2020/2021175 0 0 11 3 2 124 8 2 9 6 8 2
2021/20221.271 1 58 30 577 61 63 90 75 42 69 55 150
2022/202310.104 4.863 1.736 598 119 68 1.009 434 605 272 96 149 155
2023/20245.155 233 279 399 356 413 922 292 508 90 380 562 721
2024/202513.946 4.236 726 541 671 691 2.345 4.168 568 0 0 0 0
Totale 31.230